SCHEMBL3076853

SCHEMBL3076853

CCC(C)OP(=O)(O)c1ccc(Cl)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
GGPS1 O95749 1/20 0.38
CA1 P00915 1/20 0.38
CA14 Q9ULX7 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TDP1 Q9NUW8 2/20 0.36
MEN1 O00255 1/20 0.36
NR1I2 O75469 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.36
THRB P10828 1/20 0.36
RECQL P46063 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1725585 0.87 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1TDP1MEN1NR1I2
SCHEMBL6253592 0.84 ALDH1A1 (0.36) SMN1; SMN2CA1ALDH1A1TDP1MEN1
SCHEMBL1629974 0.83 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1TDP1THRBMAPT
SCHEMBL11050246 0.79 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1MEN1KMT2APOLB
SCHEMBL914853 0.78 HTT (0.39) SMN1; SMN2CA14ALDH1A1MEN1KMT2A
SCHEMBL10237167 0.78 KMT2A (0.49) SMN1; SMN2GGPS1CA1CA14ALDH1A1
SCHEMBL916036 0.77 HPGD (0.38) ALDH1A1MEN1KMT2ATHRBRECQL
SCHEMBL6926403 0.76 DAO (0.46)
SCHEMBL1723654 0.75 TAS1R3 (0.38) SMN1; SMN2TDP1MEN1KMT2AHPGD
SCHEMBL13457508 0.73 TDP1 (0.49) SMN1; SMN2ALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193372-B2 Phosphothiophene and phosphothiazole HCV polymerase inhibitors IDENIX PHARMACEUTICALS, INC. (US) 2012-06-05 US disclosed
US-20100233123-A1 PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100233123-A1 PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS PPP3CB, POLR2E, PSAT1 SMN1; SMN2 4434/4885GGPS1 1292/4885CA1 4370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.